Brigit Biofarmaka Teknologi Tbk. vs Semen Indonesia (Persero) Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Semen Indonesia (Persero) Tbk. trades at Rp1,520 (market cap 10.16T, 13.77M 24h volume). The key difference: Semen Indonesia (Persero) Tbk. is far larger — about 58.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Semen Indonesia (Persero) Tbk. is more actively traded (13.77M versus 592.2K). Which is the better fit depends on your goals.
| OBAT | SMGR | |
|---|---|---|
Market Cap | 172.82B | 10.16T |
Volume | 592.2K | 13.77M |
Lot | 5.92K | 137.74K |
Turnover | 147.05M | 20.91B |
Average Price | 248.31 | 1,518.47 |
Value | 147.05M | 20.91B |
Indicative Equilibrium Price | 254 | 1,520 |
Indicative Equilibrium Volume | 10 | 6.87K |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Semen Indonesia (Persero) Tbk was established on March 25,1953 as NV Pabrik Semen Gresik. On April 17, 1961,NV Pabrik Semen Gresik was transformed into a state enterprise (Persero) by Government Regulation No. 132 year 1961, and subsequently became PT Semen Gresik (Persero). Semen Gresik is a cement producer which was formerly fully owned by the government. On July 1995 the company shareholders meeting agreed to acquired 100% share of two state owned cement producer companies, namely PT. Semen Tonasa and PT. Semen Padang.
Read more on SMGR →